HEALTH PROFESSIONAL · SOURCE READING
Complete Resection With or Without Radiation Therapy
Source: Childhood Craniopharyngioma Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: November 26, 2024 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary.
Context: Treatment of Newly Diagnosed Childhood Craniopharyngioma
It may be possible to remove all visible tumor and achieve long-term disease control.[2-4][Level of evidence C1] A 5-year progression-free survival (PFS) rate of about 65% has been reported.[5] Reported recurrence rates range from less than 10% to nearly 50%.[6,7] Gross-total resection is often technically challenging because the tumor is surrounded by vital structures, including the optic nerves and chiasm, the carotid artery and its branches, the pituitary and hypothalamus, and the third cranial nerve. These structures may limit the ability to remove the entire tumor. Conservative surgical approaches are often used to preserve functional and quality-of-life outcomes.[8,9][Level of evidence C1]
Source links and citations
Many surgical approaches have been described, and the choice is determined by tumor size, location, extension, and the patient's baseline signs and symptoms of disease. Surgical approaches include the following:
Craniotomy: As noted above, gross-total resection may be technically challenging because the tumor is surrounded by vital structures. The surgeon often has a limited view of the hypothalamic and sellar regions, and portions of the mass may remain after surgery, accounting for some recurrences. An understanding of the complex variations in how the tumors grow anatomically may help facilitate gross-total resection.[10] Nonetheless, almost all craniopharyngiomas attach to the pituitary stalk. Of the patients who undergo complete resection, virtually all will require lifelong pituitary hormone replacement with multiple medications.[3,11]
Transsphenoidal approach: A transsphenoidal approach has been proven possible in patients of all ages and for tumors of various sizes localized within the sella.[12]; [13][Level of evidence C1] The development of expanded endonasal techniques with endoscopic visualization has allowed increased use of this approach, even for sizeable childhood tumors, which is similar to the experience in adults.[14] A complete resection can be obtained using this approach, with associated complications of panhypopituitarism and the risk of cerebrospinal fluid leaks.[15,16] When an endonasal approach is not possible, a craniotomy is required.
Complications of complete resection using either approach include the following:
Obesity, which can be life-threatening.[17]
Source links and citations
Need for hormone replacement therapy.[18]
Source links and citations
Severe behavioral problems.[18]
Source links and citations
Blindness.
Seizures.
Spinal fluid leak.
False aneurysms.
Difficulty with eye movements.
Death from intraoperative hemorrhage, hypothalamic damage, or stroke (rare).
If the surgeon indicates that the tumor was not completely removed or if postoperative imaging reveals residual craniopharyngioma, radiation therapy may be recommended to prevent early progression.[19][Level of evidence C2] For more information, see the Subtotal Resection With Radiation Therapy section.
Source links and citations
Routine surveillance using magnetic resonance imaging is performed for several years after complete resection because of the possibility of tumor recurrence.
Publication references
Read the original reference and check its publication notices.
- PubMed 16270681 · Original source
- PubMed 18352781 · Original source
- PubMed 19018151 · Original source
- PubMed 20043735 · Original source
- PubMed 20367362 · Original source
- PubMed 20828839 · Original source
- PubMed 21214336 · Original source
- PubMed 21490122 · Original source
- PubMed 22920295 · Original source
- PubMed 23240846 · Original source
- PubMed 27903115 · Original source
- PubMed 27903117 · Original source
- PubMed 28155902 · Original source
- PubMed 30257123 · Original source
- PubMed 31629927 · Original source
- PubMed 32204653 · Original source
- PubMed 36574377 · Original source
- PubMed 37213301 · Original source
Preserved source evidence · Not medical advice
Triangle